{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:56:14Z","timestamp":1781510174205,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.msard.2025.106873","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:39:22Z","timestamp":1764779962000},"page":"106873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neuropsychologic impact of MOGAD: A patient reported outcomes study"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1918-3818","authenticated-orcid":false,"given":"Bruna","family":"Leles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe A.","family":"Bilodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Vishnevetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Wruble Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Salky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Romanow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna S.","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2025.106873_bib0001","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2025.106873_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106873_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42780","article-title":"Factors associated with relapse and treatment of myelin oligodendrocyte glycoprotein antibody-associated disease in the United Kingdom","volume":"5","author":"Satukijchai","year":"2022","journal-title":"JAMA Netw. Open."},{"issue":"5","key":"10.1016\/j.msard.2025.106873_bib0004","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamaneurol.2022.0489","article-title":"Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"79","author":"Chen","year":"2022","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.msard.2025.106873_bib0005","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.msard.2025.106873_bib0006","article-title":"Fatigue is a common symptom in myelin oligodendrocyte glycoprotein antibody disease","volume":"8","author":"Ladakis","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"9","key":"10.1016\/j.msard.2025.106873_bib0007","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/1352458520964415","article-title":"Brain structural and functional alterations in MOG antibody disease","volume":"27","author":"Zhuo","year":"2021","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2025.106873_bib0008","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-0041-1723955","article-title":"Neuropsychological phenotypes of pediatric anti-myelin oligodendrocyte glycoprotein associated disorders: a case series","volume":"52","author":"Tan","year":"2021","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.msard.2025.106873_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103689","article-title":"Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","volume":"59","author":"Fabri","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2025.106873_bib0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fneur.2020.00778","article-title":"Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies","volume":"11","author":"Asseyer","year":"2020","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106873_bib0011","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/ene.14729","article-title":"Pain, depression, and quality of life in adults with MOG-antibody-associated disease","volume":"28","author":"Asseyer","year":"2021","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106873_bib0012","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.26858","article-title":"Time to disability milestones and annualized relapse rates in NMOSD and MOGAD","volume":"95","author":"Duchow","year":"2024","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2025.106873_bib0013","doi-asserted-by":"crossref","first-page":"e1184","DOI":"10.1212\/WNL.0000000000200052","article-title":"Costs and health-related quality of life in patients with NMO spectrum disorders and MOG-antibody-associated disease: CHANCENMO study","volume":"98","author":"H\u00fcmmert","year":"2022","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2025.106873_bib0014","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual. Life Res."},{"issue":"7","key":"10.1016\/j.msard.2025.106873_bib0015","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/arclin\/acaa128","article-title":"Normative reference values, reliability, and item-level symptom endorsement for the PROMIS\u00ae v2.0 cognitive function-short forms 4a, 6a and 8a","volume":"36","author":"Iverson","year":"2021","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"11","key":"10.1016\/j.msard.2025.106873_bib0016","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1007\/s11606-007-0333-y","article-title":"Screening for depression in medical settings with the patient health questionnaire (PHQ): a diagnostic meta-analysis","volume":"22","author":"Gilbody","year":"2007","journal-title":"J. Gen. Intern. Med."},{"issue":"6","key":"10.1016\/j.msard.2025.106873_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2019-100144","article-title":"Anxiety symptoms questionnaire (ASQ): development and validation","volume":"32","author":"Baker","year":"2019","journal-title":"Gen. Psych."},{"issue":"1","key":"10.1016\/j.msard.2025.106873_bib0018","doi-asserted-by":"crossref","first-page":"15","DOI":"10.7224\/1537-2073.2012-019","article-title":"Psychometric properties of the modified fatigue impact scale","volume":"15","author":"Larson","year":"2013","journal-title":"Int. J. MS. Care"},{"issue":"7","key":"10.1016\/j.msard.2025.106873_bib0019","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item national eye institute visual function questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch. Ophthalmol."},{"issue":"2","key":"10.1016\/j.msard.2025.106873_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.msard.2025.106873_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.msard.2025.106873_bib0022","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jad.2020.09.131","article-title":"Screening for depression in primary care with patient health questionnaire-9 (PHQ-9): a systematic review","volume":"279","author":"Costantini","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.msard.2025.106873_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102576","article-title":"Tired of not knowing what that fatigue score means? normative data of the modified fatigue impact scale (MFIS)","volume":"46","author":"Strober","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.msard.2025.106873_bib0024","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008","volume":"63","author":"Cella","year":"2010","journal-title":"J. Clin. Epidemiol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825006157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:48:56Z","timestamp":1781509736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825006157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"alternative-id":["S2211034825006157"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106873","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychologic impact of MOGAD: A patient reported outcomes study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106873"}}